Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UNIPROT:Q06643 (non-Hodgkin's lymphoma)
11,307 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

In a retrospective study of 301 non-Hodgkin's lymphoma patients the clinical and prognostic value of the classification of Lukes and Collins was studied. A slight majority of the cases were of the follicular center cell types. Stages III-IV were found in 46% of the entire group at the time of diagnosis. The lymphomas showing follicular center cell types were frequently localized (63%). About 65% of all cases survived one year and about 45% five years. The females showed a better survival. The nodal lymphoma cases had the poorest survival. Two prognostically different subgroups of non-Hodgkin's lymphomas were discerned. The more favourable group consisted of the small cleaved FCC type (five-year relative survival 74%), the small lymphocytic type (62%) and the plasmacytoid lymphocytic type (51%). The small non-cleaved FCC type, the large non-cleaved FCC type and the immunoblastic sarcoma type formed the other group with a less favourable prognosis. Mortality due to these types manifested itself to a level of 65% in the first two years.
...
PMID:The Lukes and Collins classification of non-Hodgkin's lymphomas. 2. A survival study of 301 patients. 712 96

Despite their generally favorable mortality experience, general occupational surveys of farmers suggest they have elevated risks of cancer of the lymphatic and hematopoietic systems, stomach, prostate, brain, and skin. Since farmers often serve in the role of mechanic, carpenter, welder, pesticide applicator, and veterinarian, they may be exposed to many potentially hazardous substances. The types and levels of exposures have been discussed by others earlier in the program. The evidence is strongest for the association between farming and risk of leukemia. However, the specific leukemogenic agent or agents have yet to be identified. Leukemia excesses among poultrymen and dairy farmers suggest involvement of zoonotic viruses, while associations with crop production is more indicative of pesticide usage. The associations regarding other cancers (i.e., Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, soft-tissue sarcoma, and cancers of the stomach, brain, and prostate) are even less clear. However, the Swedish reports of high risk of soft-tissue sarcomas and lymphomas among persons exposed to herbicides is particularly disconcerting and underscores the urgent need for similar epidemiologic studies in the U.S. Several case-control interview studies are underway that should help clarify the role of agricultural factors in the origin of various cancers. NCI is sponsoring studies of leukemia and non-Hodgkin's lymphoma among men from Minnesota and Iowa. Detailed information on farm practices and pesticide usage is being gathered. A study of soft-tissue sarcoma, Hodgkin's disease, and non-hodgkin's lymphoma also has just been initiated. This investigation is located in Kansas, a major wheat producing area. A wheat producing area was selected because herbicides are more heavily used on this crop than insecticides. The major objective of this project is to evaluate the role of herbicides in the origin of these cancers. A case-control study of brain cancer has also recently been initiated. Although this study focuses on contact with petrochemicals, a complete work history will be obtained and would note any farm experience. These data may help clarify the reported association between brain cancer and farming.
...
PMID:Cancer risks associated with agriculture: epidemiologic evidence. 715 Feb 8

Mediastinal masses in children constitute a heterogeneous group of malignant and benign neoplasms. The majority of malignant tumors in our series of 188 children with a mediastinal mass were Hodgkin's and non-Hodgkin's lymphoma (87 patients) arising in the anterior and middle mediastinum. Ganglioneuroma (17) arising in the posterior mediastinum made up the bulk of benign tumors (52). Infants less than 2 yr old presented with symptoms of tracheal compression, whereas older children had fewer symptoms but a far greater likelihood of having a malignancy. In the assessment of patients with mediastinal tumors, the posteroanterior and lateral chest roentgenograms were most often diagnostic, and computed tomography of the chest provided the most information concerning preoperative resectability. The excellent survival of patients with stage I and II Hodgkin's disease reflects the radiosensitivity of the tumor; in our series of 33 patients, survival was not increased by radical resection. Unlike lymphomatous tumors, neurogenic masses should be completely excised. When initial exploration reveals unresectability, biopsy followed by radiation therapy and second-look excision of the tumor can be accomplished. In patients with primary mediastinal sarcomas, total resection should be carried out if possible. In our series, adjuvant radiation therapy or chemotherapy was effective in only 1 of 15 children with sarcoma. Surgical treatment of all mediastinal masses except lymphoma should be complete excision. In cases of suspected lymphoma, cervical or supraclavicular node biopsy can yield adequate tissue for diagnosis.
...
PMID:Primary mediastinal tumors in children. 717 38

We have utilized a recently developed human tumor cloning system to screen for antitumor effects in vitro of a new anthracenedione derivative, Mitoxantrone. The object was to determine if the system is useful for pinpointing the types of tumors in patients which should be studied in early Phase II clinical trials. Tumors from 267 patients were placed in culture (20 different histological tumor types). One hundred seventy tumors both grew and formed enough colonies for drug sensitivity assays. Excellent in vitro antitumor activity was noted for Mitoxantrone against human adenocarcinoma of the lung, small cell lung cancer, melanoma, and biliary tree cancer. Good antitumor activity was noted against breast cancer, ovarian cancer, non-Hodgkin's lymphoma, head and neck cancer, squamous cell lung cancer, soft tissue sarcoma, gastric cancer, and hepatomas. The drug showed no in vitro activity against colon cancer. These data indicate that Mitoxantrone has a wide spectrum of in vitro antitumor activity. A comparison of these in vitro results with the results of Phase II clinical trials with the drug should allow an evaluation of the utility of the human tumor cloning system for predicting clinical antitumor activity of a new compound.
...
PMID:Activity of mitoxantrone in a human tumor cloning system. 721 52

A survey of 63 patients with malignant tumour of the nasopharynx, treated over a 20-year period (1958-1977) is presented. The major types of tumour were squamous cell and anaplastic carcinoma (including lymphoepithelioma) and non-Hodgkin's lymphoma. In some patients other tumours were found, such as cylindroma, rhabdomyosarcoma and extramedullary plasmocytoma. A particularly high incidence of men younger than 40 years was seen with carcinoma and an occupation in a particular branch of industry, indicated as 'metallurgic or allied' (light engineering factories, garages etc). 60Co irradiation was the primary therapy. Adjuvant chemotherapy was used in lymphoma or sarcoma. The survival was significantly better in the younger age group as far as carcinoma is concerned. The possible role of occupational factors is discussed in relation to findings in the literature.
...
PMID:Nasopharyngeal cancer: a clinical study with special reference to age and occupation. 736 91

Three hundred and thirty-six patients with a variety of tumors were treated with Adriamycin given weekly as an iv bolus of 1 mg/kg with subsequent doses adjusted for hematologic toxicity. This weekly schedule, not utilizing a loading course, resulted in only a 20% incidence of stomatitis. The number of evaluable patients and the percent with objective responses (respectively) according to tumor type were: lung (57 patients, 14%); sarcoma (62, 24%); breast (31, 35%); transitional cell carcinoma (17, 29%); non-Hodgkin's lymphoma (17, 29%); head and neck (16, 13%); colorectal (13, 0); ovarian (eight, 25%); and other (53, 11%). These response frequencies are comparable to those reported for every-3-week regimens using 60-75 mg/m2 of Adriamycin. Sixteen patients were given 450-550 mg/m2 of Adriamycin, five were given 550-600 mg/m2, and ten were given greater than 600 mg/m2. None of the study patients developed definite evidence of drug-induced congestive heart failure. Therefore, Adriamycin given as a weekly schedule provides a clinically effective alternative to the every-3-week schedule of administration. The weekly schedule is associated with tolerable toxicity and a decreased risk of developing drug-induced congestive heart failure.
...
PMID:Adriamycin given as a weekly schedule without a loading course: clinically effective with reduced incidence of cardiotoxicity. 737 58

The FAU gene is the cellular homologue of the viral FOX sequences in the genome of the Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV); the viral FOX sequences have been shown to increase the transforming capacity of FBR-MuSV in vitro. The human FAU gene has recently been isolated, characterized, and mapped to chromosome band 11q13. Here, we report results of fluorescence in situ hybridization (FISH) analysis which indicate that the FAU gene maps proximally to the putative oncogene BCL1 at 11q13. Furthermore, we identified a t(11;17)(q13;q21) translocation in tumor cells of a t(11;14)(q13;q32)-positive B-cell non-Hodgkin's lymphoma patient by FISH analysis using a FAU containing cosmid clone as molecular probe and by double-colour chromosome painting analysis using chromosome 11- and chromosome 17-specific painting probes. The position of the chromosome 11 breakpoint of the t(11;17) translocation was pinpointed to a human DNA region around the FAU gene of about 40 kbp.
...
PMID:Molecular mapping of the chromosome 11 breakpoint of t(11;17)(q13;q21) in a t(11;14)(q13;q32)-positive B non-Hodgkin's lymphoma. 751 65

In a study of abnormal chromosomes in non-Hodgkin's lymphoma (NHL) cells we have identified one case which contained extrachromosomal chromatin bodies that, on the basis of their morphology and negative C-banding, appeared to be double minute chromosomes (dmin). However, fluorescence in-situ hybridization (FISH) analysis using an X-specific centromeric alphoid repeat probe and a pan-centromere probe, clearly demonstrated the presence of centromere-associated DNA in these dmin. FISH analysis with the pan-centromere probe of the dmin in neuroblastoma and sarcoma cells failed to reveal the presence of centromere-associated DNA, but analysis of two cases of acute myeloid leukemia cells revealed centromere-associated DNA in 25% of their dmin. These data indicate the existence of dmin that contain centromere-associated DNA and suggest that such dmin might represent a new class of extrachromosomal chromatin bodies.
...
PMID:Identification of a subclass of double minute chromosomes containing centromere-associated DNA. 752 Feb 68

In order to ascertain the frequency and distribution of isochromosomes in neoplasia, we surveyed the cytogenetic data from 20,007 tumors with clonal chromosome aberrations reported in the literature. Tumor types for which at least 50 cases with acquired aberrations and 10 cases with isochromosomes had been reported were selected, yielding a total of 18,160 neoplasms. Of these, 1,792 cases (9.9%) displayed a total of 2,014 isochromosomes. The 9 most common isochromosomes (detected in at least 50 cases) were, in decreasing order of frequency, i(17q), i(8q), i(1q), i(12p), i(6p), i(7q), i(9q), i(5p), and i(21q). The frequency of isochromosomes varied among the different tumor types, with the highest incidence in germ cell neoplasms (60%) and the lowest in chronic myeloproliferative disorders (2.3%). Also, the spectrum of isochromosomes differed among the neoplasms. The most common isochromosomes in the different tumor types were i(11q), i(17q), and i(21q) in acute myeloid leukemia; i(9q), i(17q), and i(22q) in chronic myeloid leukemia; i(17q) in chronic myeloproliferative disorders; i(X)(q13), i(17q), and i(21q) in myelodysplastic syndromes; i(7q), i(9q), and i(17q) in acute lymphoblastic leukemia; i(1q), i(7q), i(8q), and i(17q) in chronic lymphoproliferative disorders; i(1q), i(6p), i(9p), i(17q), and i(21q) in Hodgkin's disease; i(1q), i(6p), and i(17q) in non-Hodgkin's lymphoma; i(1q), i(8q), and i(17q) in adenocarcinoma; i(1q), i(3q), i(5p), and i(8q) in squamous cell carcinoma; i(5p), i(8q), and i(11q) in transitional cell carcinoma; i(1q), i(7q), and i(17q) in Wilms' tumor; i(1q), i(12p), and i(17q) in germ cell neoplasms; i(1p), i(1q), i(6p), and i(17q) in sarcoma; i(5p), i(6p), i(7p), and i(21q) in mesothelioma; i(1q), i(6p), and i(17q) in malignant neurogenic neoplasms; i(1q), i(6p), and i(17q) in retinoblastoma; and i(1q), i(6p), and i(8q) in malignant melanoma.
...
PMID:Isochromosomes in neoplasia. 752 35

We examined the effect of exposure to chemicals present in the production and spraying of phenoxy herbicides or chlorophenols in two nested case-control studies of soft tissue sarcoma and non-Hodgkin's lymphoma. Eleven sarcoma and 32 lymphoma cases occurring within an international cohort were matched for age, sex, and country of residence with 55 and 158 controls, respectively. Exposures to 21 chemicals or mixtures were estimated by three industrial hygienists who were blind to the subject's case-control status. Excess risk of soft tissue sarcoma was associated with exposure to any phenoxy herbicide [odds ratio (OR) = 10.3; 95% confidence interval (CI) = 1.2-91] and to each of the three major classes of phenoxy herbicides (2,4-dichlorophenoxyacetic acid, 2,4,5-trichlorophenoxyacetic acid, and 4-chloro-2-methylphenoxyacetic acid), to any polychlorinated dibenzodioxin or furan (OR = 5.6; 95% CI = 1.1-28), and to 2,3,7,8-tetrachlorodibenzo-p-dioxin (OR = 5.2; 95% CI = 0.85-32). Sarcoma risk was not associated with exposure to raw materials or other process chemicals. In the non-Hodgkin's lymphoma study, associations were generally weaker than those found in the study on sarcoma. These findings indicate that workers exposed to phenoxy herbicides and their contaminants are at a higher risk of soft tissue sarcoma.
...
PMID:Soft tissue sarcoma and non-Hodgkin's lymphoma in workers exposed to phenoxy herbicides, chlorophenols, and dioxins: two nested case-control studies. 754 48


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>